Global Bioprocessing Systems 麻豆原创 Research Report 2023

Publication ID:

PB502234801

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Manufacturing biologics is a complicated process and thus generally are outsourced by the manufacturers. Bioprocessing is the manufacturing process which helps in producing bio-based products such as vegetable oils, and fatty acids. The major applications of bioprocess industry are vaccines, tissue engineering, biosensors, and biopharmaceuticals. Bioprocessing also is known as biopharmaceutical manufacturing is a bioprocess used for the production of therapeutic cells.
Highlights
The global Bioprocessing Systems market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global bioprocessing systems market witnessed significant growth owing to increasing demand for bio-based products. The heavy demand for such systems by the industries such as food, pharmaceuticals, neutraceuticals, chemicals and polymers coupled with automation in the industrial process minimizing human errors have propelled the growth of global bioprocessing market. Moreover, the factors such as rising demand for biopharmaceutical production, increasing symptoms of chronic diseases, low manufacturing costs as compared to the artificial source of materials and improvisation of infrastructure in life science research has triggered the global bioprocessing systems during the forecast period 2017-2027. Growing demand for the single 鈥搖se systems of the bioprocessing systems is expected to gain traction during the forecast period which is supposed to augment the global bioprocessing system market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioprocessing Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioprocessing Systems.
The Bioprocessing Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bioprocessing Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioprocessing Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech
Segment by Type
Upstream
Downstream
Single Use
Integrated
Segment by Application
Vaccine Development
Cell Therapy and Plant Cell Cultivation
Filters
Tissue Engineering
Biosensors
Bioreactors and Mixers
Plasma Fractionation
Chromatography
Bio-therapeutic Molecule Production
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioprocessing Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioprocessing Systems 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Upstream
1.2.3 Downstream
1.2.4 Single Use
1.2.5 Integrated
1.3 麻豆原创 by Application
1.3.1 Global Bioprocessing Systems 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccine Development
1.3.3 Cell Therapy and Plant Cell Cultivation
1.3.4 Filters
1.3.5 Tissue Engineering
1.3.6 Biosensors
1.3.7 Bioreactors and Mixers
1.3.8 Plasma Fractionation
1.3.9 Chromatography
1.3.10 Bio-therapeutic Molecule Production
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioprocessing Systems 麻豆原创 Perspective (2018-2029)
2.2 Bioprocessing Systems Growth Trends by Region
2.2.1 Global Bioprocessing Systems 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioprocessing Systems Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Bioprocessing Systems Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Bioprocessing Systems 麻豆原创 Dynamics
2.3.1 Bioprocessing Systems Industry Trends
2.3.2 Bioprocessing Systems 麻豆原创 Drivers
2.3.3 Bioprocessing Systems 麻豆原创 Challenges
2.3.4 Bioprocessing Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioprocessing Systems Players by Revenue
3.1.1 Global Top Bioprocessing Systems Players by Revenue (2018-2023)
3.1.2 Global Bioprocessing Systems Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Bioprocessing Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioprocessing Systems Revenue
3.4 Global Bioprocessing Systems 麻豆原创 Concentration Ratio
3.4.1 Global Bioprocessing Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioprocessing Systems Revenue in 2022
3.5 Bioprocessing Systems Key Players Head office and Area Served
3.6 Key Players Bioprocessing Systems Product Solution and Service
3.7 Date of Enter into Bioprocessing Systems 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioprocessing Systems Breakdown Data by Type
4.1 Global Bioprocessing Systems Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Bioprocessing Systems Forecasted 麻豆原创 Size by Type (2024-2029)
5 Bioprocessing Systems Breakdown Data by Application
5.1 Global Bioprocessing Systems Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Bioprocessing Systems Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Bioprocessing Systems 麻豆原创 Size (2018-2029)
6.2 North America Bioprocessing Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bioprocessing Systems 麻豆原创 Size by Country (2018-2023)
6.4 North America Bioprocessing Systems 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioprocessing Systems 麻豆原创 Size (2018-2029)
7.2 Europe Bioprocessing Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bioprocessing Systems 麻豆原创 Size by Country (2018-2023)
7.4 Europe Bioprocessing Systems 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioprocessing Systems 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Bioprocessing Systems 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bioprocessing Systems 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Bioprocessing Systems 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioprocessing Systems 麻豆原创 Size (2018-2029)
9.2 Latin America Bioprocessing Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bioprocessing Systems 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Bioprocessing Systems 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioprocessing Systems 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Bioprocessing Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bioprocessing Systems 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Bioprocessing Systems 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Bioprocessing Systems Introduction
11.1.4 Lonza Revenue in Bioprocessing Systems Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Pall Corporation
11.2.1 Pall Corporation Company Detail
11.2.2 Pall Corporation Business Overview
11.2.3 Pall Corporation Bioprocessing Systems Introduction
11.2.4 Pall Corporation Revenue in Bioprocessing Systems Business (2018-2023)
11.2.5 Pall Corporation Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Bioprocessing Systems Introduction
11.3.4 GE Healthcare Revenue in Bioprocessing Systems Business (2018-2023)
11.3.5 GE Healthcare Recent Development
11.4 Nordson MEDICAL's
11.4.1 Nordson MEDICAL's Company Detail
11.4.2 Nordson MEDICAL's Business Overview
11.4.3 Nordson MEDICAL's Bioprocessing Systems Introduction
11.4.4 Nordson MEDICAL's Revenue in Bioprocessing Systems Business (2018-2023)
11.4.5 Nordson MEDICAL's Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Bioprocessing Systems Introduction
11.5.4 Thermo Fisher Scientific Revenue in Bioprocessing Systems Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 EMD Millipore Corporation
11.6.1 EMD Millipore Corporation Company Detail
11.6.2 EMD Millipore Corporation Business Overview
11.6.3 EMD Millipore Corporation Bioprocessing Systems Introduction
11.6.4 EMD Millipore Corporation Revenue in Bioprocessing Systems Business (2018-2023)
11.6.5 EMD Millipore Corporation Recent Development
11.7 PBS Biotech
11.7.1 PBS Biotech Company Detail
11.7.2 PBS Biotech Business Overview
11.7.3 PBS Biotech Bioprocessing Systems Introduction
11.7.4 PBS Biotech Revenue in Bioprocessing Systems Business (2018-2023)
11.7.5 PBS Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Lonza
Pall Corporation
GE Healthcare
Nordson MEDICAL's
Thermo Fisher Scientific
EMD Millipore Corporation
PBS Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.